Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes

• Published in: Biochemical and biophysical research communications Vol. 361; no. 3; pp. 687 - 693
• Main Authors: Santucci, Marilina B., Greco, Emanuela, De Spirito, Marco, Arcovito, Giuseppe, De Angelis, Giulia, Cauda, Roberto, Fraziano, Maurizio
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 28-09-2007
• Subjects: Adult; Antigen Presentation; Antigens, CD - immunology; Antigens, Differentiation, T-Lymphocyte - immunology; CCR5; CD4-Positive T-Lymphocytes - immunology; Cell Line, Tumor; Female; Humans; IFN-γ; Interferon-gamma - biosynthesis; Interferon-gamma - immunology; Lectins, C-Type; Lysophospholipids - metabolism; Male; Monocytes - immunology; Monocytes - microbiology; Mycobacterium tuberculosis; Mycobacterium tuberculosis - immunology; Patients; Sphingosine - analogs & derivatives; Sphingosine - metabolism; Sphingosine 1-phosphate; Antigen presentation; IFN-γ; Mycobacterium tuberculosis; CCR5; Patients; Sphingosine 1-phosphate
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2007.07.087

Sphingosine 1-phosphate (S1P) has recently been described to induce antimycobacterial activity. The present study analyses the role played by S1P in antigen presentation of monocytes and in the next activation of
Mycobacterium tuberculosis (MTB)-specific CD4+ T cell response. Results reported herein show that S1P stimulation of MTB-infected monocytes (i) inhibits intracellular mycobacterial growth, (ii) enhances phagolysosome maturation and the transit of mycobacteria in MHC class II compartments, (iii) increases the frequency of MTB-specific CD4+CD69+ T cells, expressing the inflammatory homing receptor CCR5, derived from tuberculosis patients and PPD+, BCG naïve, healthy subjects, and (iv) induces IFN-γ production in CD4+CD69+CCR5+ T cells derived from PPD+ healthy individuals, only. Altogether, these results show that S1P promotes antigen processing and presentation in monocytes, increases the frequency of MTB-specific CD4+ T cells and can regulate IFN-γ production by antigen specific CD4+ T cells in the course of active disease.